(Q34027502)

30 July 2017

1 reference

title

Deactivation of the sympathetic nervous system in patients with chronic congestive heart failure (English)

1 reference

30 July 2017

main subject

congestive heart failure

1 reference

E M Gilbert

1

1 reference

30 July 2017

J D Port

series ordinal

2

1 reference

30 July 2017

publication date

1 May 2000

1 reference

Current cardiology reports

30 July 2017

published in

1 reference

30 July 2017

volume

2

1 reference

30 July 2017

issue

3

1 reference

30 July 2017

page(s)

225-232

1 reference

Altered expression of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart.

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11886-000-0073-7

Adrenergic receptor stimulation of the mitogen-activated protein kinase cascade and cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-000-0073-7

The molecular basis for distinct beta-adrenergic receptor subtype actions in cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-000-0073-7

Assessment of the beta-adrenergic receptor pathway in the intact failing human heart: progressive receptor down-regulation and subsensitivity to agonist response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-000-0073-7

Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-000-0073-7

Comparative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-000-0073-7

Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure

21 January 2018

1 reference

12 December 2020

Betaxolol versus carvedilol in chronic heart failure (BETACAR study). Rationale and design

1 reference

12 December 2020

cDNA for the human beta 2-adrenergic receptor: a protein with multiple membrane-spanning domains and encoded by a gene whose chromosomal location is shared with that of the receptor for platelet-derived growth factor

1 reference

12 December 2020

The sympathetic nervous system in chronic heart failure

1 reference

12 December 2020

Effects of carvedilol on left ventricular mass, chamber geometry, and mitral regurgitation in chronic heart failure

1 reference

12 December 2020

Carvedilol inhibits reactive oxygen species generation by leukocytes and oxidative damage to amino acids

1 reference

12 December 2020

Beta-blockade in heart failure: a comparison of carvedilol with metoprolol

1 reference

12 December 2020

Role of beta-adrenergic receptor downregulation in the peak exercise response in patients with heart failure due to idiopathic dilated cardiomyopathy

1 reference

12 December 2020

Receptor pharmacology of carvedilol in the human heart

1 reference

12 December 2020

Cardiomyopathy induced by cardiac Gs alpha overexpression

1 reference

12 December 2020

Beta 1- and beta 2-adrenergic receptor-mediated adenylate cyclase stimulation in nonfailing and failing human ventricular myocardium

1 reference

12 December 2020

Design of the Beta-Blocker Evaluation Survival Trial (BEST). The BEST Steering Committee

1 reference

12 December 2020

Xamoterol in severe heart failure. The Xamoterol in Severe Heart Failure Study Group

1 reference

12 December 2020

Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes

1 reference

12 December 2020

Molecular characterization of the human beta 3-adrenergic receptor

1 reference

12 December 2020

Cloning of the cDNA for the human beta 1-adrenergic receptor

1 reference

12 December 2020

Efficacy of beta 1-adrenergic receptors is lower than that of beta 2-adrenergic receptors

1 reference

12 December 2020

Adrenergic effects on the biology of the adult mammalian cardiocyte

1 reference

12 December 2020

Differential coupling of alpha1-, alpha2-, and beta-adrenergic receptors to mitogen-activated protein kinase pathways and differentiation in transfected PC12 cells

1 reference

12 December 2020

Beta-adrenergic receptor blockade arrests myocyte damage and preserves cardiac function in the transgenic G(salpha) mouse

1 reference

12 December 2020

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

1 reference

12 December 2020

Differences in beta-adrenergic neuroeffector mechanisms in ischemic versus idiopathic dilated cardiomyopathy

1 reference

12 December 2020

AKAPs: from structure to function

1 reference

12 December 2020

Switching of the coupling of the beta2-adrenergic receptor to different G proteins by protein kinase A.

1 reference

12 December 2020

Enhanced myocardial function in transgenic mice overexpressing the beta 2-adrenergic receptor

1 reference

12 December 2020

Localized cAMP-dependent signaling mediates beta 2-adrenergic modulation of cardiac excitation-contraction coupling

1 reference

12 December 2020

Cardiac function in mice overexpressing the beta-adrenergic receptor kinase or a beta ARK inhibitor

1 reference

12 December 2020

Beta-adrenergic pathways in nonfailing and failing human ventricular myocardium.

1 reference

12 December 2020

Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockade

1 reference

12 December 2020

Effect of metoprolol on myocardial function and energetics in patients with nonischemic dilated cardiomyopathy: a randomized, double-blind, placebo-controlled study

1 reference

12 December 2020

Hemodynamic predictors of early intolerance and long-term effects of propranolol in dilated cardiomyopathy

1 reference

12 December 2020

Myocardial-directed overexpression of the human beta(1)-adrenergic receptor in transgenic mice

1 reference

12 December 2020

Opposing effects of beta(1)- and beta(2)-adrenergic receptors on cardiac myocyte apoptosis : role of a pertussis toxin-sensitive G protein

1 reference

12 December 2020

Hormones and hemodynamics in heart failure

1 reference

12 December 2020

Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study

1 reference

12 December 2020

Integration of transmembrane signaling Cross-talk among G-protein-linked receptors and other signal transduction pathways

1 reference

12 December 2020

Long-term effects of carvedilol in idiopathic dilated cardiomyopathy with persistent left ventricular dysfunction despite chronic metoprolol. The Heart-Muscle Disease Study Group.

1 reference

12 December 2020

Functional beta3-adrenoceptor in the human heart

1 reference

12 December 2020

Potentiation of beta-adrenergic signaling by adenoviral-mediated gene transfer in adult rabbit ventricular myocytes

1 reference

12 December 2020

Progressive hypertrophy and heart failure in beta1-adrenergic receptor transgenic mice.

1 reference

12 December 2020

1 reference

12 December 2020

Prospective, randomized comparison of effect of long-term treatment with metoprolol or carvedilol on symptoms, exercise, ejection fraction, and oxidative stress in heart failure

1 reference

12 December 2020

Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure

1 reference

12 December 2020

10.1007/S11886-000-0073-7

Identifiers

DOI

1 reference

Dimensions Publication ID

30 July 2017

1044401924

0 references

1 reference